The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients-Reference-Cited by-同舟云学术

The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients

Published:2006 Issue:3 Volume:12 Page:475-480
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Barshes Neal R.,Lee Timothy C.,Udell Ian W.,O'Mahoney Christine A.,Karpen Saul J.,Carter Beth A.,Goss John A.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference16 articles.

1. The Survival Benefit of Liver Transplantation

2. When is a patient too well and when is a patient too sick for a liver transplant?

3. MELD and PELD: Application of survival models to liver allocation

4. New liver allocation policies and their potential effect on pediatric patients awaiting liver transplantation

5. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes and risk factors for early bacterial infection after pediatric liver transplantation: a prospective cohort study;International Journal of Surgery;2024-06-04

2. MELD 3.0 in Advanced Chronic Liver Disease;Annual Review of Medicine;2024-01-29

3. Evaluating the Association between Anemia and the Severity of Liver Disease in Children with Cirrhosis: A Cross-Sectional Study from 2015 to 2020;Pediatric Gastroenterology, Hepatology & Nutrition;2024

4. Results of 950 pediatric liver transplants: prognostic factors, learning curve and impact on one-year survival;Journal of Pediatric Surgery Open;2023-12

5. Impact of preoperative bloodstream infection on outcomes of pediatric liver transplant recipients treated for acute liver failure;Transplant Infectious Disease;2023-11-27